Table 1.
Demographic data of HDs, new-onset SLE and RA patients in this study
| HDs (n = 40) | SLE (n = 64) | RA (n = 20) | |
|---|---|---|---|
| Age, mean (range) | 35.18 (21–54) | 32.31 (15–54) | 49.74 (20–71) |
| Sex (female/male) | 90% (36:4) | 93.75% (60:4) | 85% (17:3) |
| SLEDAI, mean (range) | NA | 13.35 (2–44) | NA |
| Fever (%) | NA | 1.72% | NA |
| Rash (%) | NA | 52.73% | NA |
| Alopecia, n (%) | NA | 12.73% | NA |
| Arthritis (%) | NA | 58.18% | NA |
| Oral ulcer (%) | NA | 21.82% | NA |
| Photosensitivity (%) | NA | 10.00% | NA |
| Vasculitis (%) | NA | 9.10% | NA |
| Raynaud (%) | NA | 7.55% | NA |
| Serositis (%) | NA | 19.57% | NA |
| Renal (%) | NA | 24.14% | NA |
| Hematology (%) | NA | 69.35% | NA |
| Neurology (%) | NA | 7.27% | NA |
| dsDNA (IU/ml), mean (range) | NA | 417.01 (1.16–3768) | NA |
| C3 (g/liter), mean (range) | NA | 0.53 (0.10–1.54) | NA |
Data are numbers (%) or means (range)
NA not available